GeneDx Holdings(us:WGS)

80.11

-5.61%

Updated on 2025-04-03

Open:79.62
Close:80.11
High:82.59
Low:78.00
Prev Close:84.87
Volume:772309.00
Turnover:62.27M
Turnover Ratio:2.75%
Shares:28.07M
MarketCap:2.25B
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-30971627833560.45%392423
2024-03-31671390827053.24%201617
2023-12-31591244053247.89%10825
2023-09-30621394460353.89%51725
2023-06-30961405696854.57%14082
2023-03-3110447085393758.99%173935
2022-12-3111114301868936.81%152549
2022-09-3011615825058841.49%73251
dateorgNametotalratiochangeShareschangeRatio
2024-03-31Casdin Capital, Llc313641112.01%409001.32%
2024-03-31Corvex Management Lp24737819.47%0
2024-03-31Oracle Investment Management Inc11266074.31%948253531.67%
2024-03-31Goldman Sachs Group Inc11251154.31%-561716-33.30%
2024-03-31Blackstone Inc.8350623.20%0
2024-03-31Morgan Stanley7934813.04%93531.19%
2024-03-31Soleus Capital Management, L.P.7833763.00%7233761205.63%
2024-03-31Vanguard Group Inc7076122.71%286784.22%
2024-03-31Deerfield Management Company, L.P. (Series C)6431102.46%0
2024-03-31Gagnon Securities Llc5563052.13%20702759.27%

About

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
Address:North Tower,333 Ludlow Street,8th floor

Market Movers